Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 48 record(s)

Req # A-2020-001486

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-100273-135, 2020 Public Health Agency of Canada Awards Launch.

Organization: Health Canada

14 page(s)
August 2021

Req # A-2020-001551

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-116013-691, Industry Proposal for Food Advertising Restrictions to Children.

Organization: Health Canada

73 page(s)
August 2021

Req # A-2021-000040

Adverse Drug Reaction (ADR) for GENVOYA. Report number: E2B_03707140.

Organization: Health Canada

15 page(s)
August 2021

Req # A-2021-000181

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03757230.

Organization: Health Canada

10 page(s)
August 2021

Req # A-2021-000182

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03744567.

Organization: Health Canada

11 page(s)
August 2021

Req # A-2021-000183

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03757246.

Organization: Health Canada

12 page(s)
August 2021

Req # A-2021-000250

Adverse Drug Reaction (ADR) for GLYCERYL TRINITRATE. Report number: E2B_03388071.

Organization: Health Canada

27 page(s)
August 2021

Req # A-2021-000272

Adverse Drug Reaction (ADR) for Prevegyne. Report number: E2B_03212857.

Organization: Health Canada

55 page(s)
August 2021

Req # A-2021-000290

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-106192-165, ASDM attending the Roadmap for Open Science Steering Committee.

Organization: Health Canada

30 page(s)
August 2021

Req # A-2021-000294

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-105824-424, Ministerial joint meeting with SEUI/CUPE/Unifor.

Organization: Health Canada

10 page(s)
August 2021
Date modified: